A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).

Keshtkar-Jahromi, Maryam; Bavari, Sina

Keshtkar-Jahromi, Maryam; Bavari, Sina.

Keshtkar-Jahromi M; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Bavari S; Edge BioInnovation Consulting, Frederick, Maryland.

Am J Trop Med Hyg ; 102(5): 932-933, 2020 05.

Article in English | MEDLINE | ID: covidwho-839861

Subject(s)

Antimalarials; Betacoronavirus; Chloroquine; Coronavirus Infections/drug therapy; Hydroxychloroquine; Pneumonia, Viral/drug therapy; Randomized Controlled Trials as Topic; Antimalarials/adverse effects; Antimalarials/therapeutic use; COVID-19; Chloroquine/adverse effects; Chloroquine/therapeutic use; Humans; Hydroxychloroquine/adverse effects; Hydroxychloroquine/therapeutic use; Pandemics; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Randomized Controlled Trials as Topic / Chloroquine / Coronavirus Infections / Betacoronavirus / Hydroxychloroquine / Antimalarials Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Am J Trop Med Hyg Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google